Table 1.
Option | Year of WHO guideline | Regimen for woman | Regimen for infant | GRADE rating | |
---|---|---|---|---|---|
Treatment (CD4 ≤ 350) | Prophylaxis (CD4 > 350) | ||||
Option A | 2010a | ART | Pregnancy: AZT Labour: single-dose NVP & AZT/3TC Postpartum: AZT/3TC 7 days |
NVP to 1 week after breastfeeding, or 4–6 weeks if not breastfeeding | Strong recommendation Low-quality evidence |
Option B | 2010 & 2013 | ART | Pregnancy and labour: triple ARVs Postpartum until 1 week after breastfeeding |
NVP or AZT for 4–6 weeks | 2010: Strong recommendation moderate evidence 2013: Conditional recommendation Low-quality evidence |
Option B+ | 2013 | ART, regardless of CD4 count | NVP or AZT for 4–6 weeks | Conditional recommendation Low-quality evidence |
aOption B+ included as a research priority in these guidelines